E N D
NEWBORN NEWBORN SCREENING SCREENING MARKET MARKET Market Size (2018) Market Size (2018) US$ 561.5 MN US$ 561.5 MN CAGR ( CAGR (2018 12.4% 12.4% 2018 – – 2026) 2026) © Coherent Market Insights. All Rights Reserved
Segmentation (Scope) By Product Type By Test By Applications Assay Kits Blood Test Blood Spot Disease Hearing Screening Services Cardio Test Critical Congenital Cardiac Disease Mass Spectrometer Hearing Test Maple Syrup Urine Disease Pulse Oximetry Urine Test Hearing Disability Sickle Cell Disease Thyroid Disorder © Coherent Market Insights. All Rights Reserved © Coherent Market Insights. All Rights Reserved
Major Drivers Increasing government support for newborn screening Advancement in screening technologies Increasing product approvals © Coherent Market Insights. All Rights Reserved © Coherent Market Insights. All Rights Reserved
NORTH AMERICA ASIA PACIFIC Major Drivers Major Drivers Increasing healthcare expenditure Increasing government funding for new born screening Increasing incidence of premature births Rapidly increasing healthcare industry © Coherent Market Insights. All Rights Reserved © Coherent Market Insights. All Rights Reserved
Major Players Agilent Technologies Natus Medical Inc. GE Life Sciences Bio-Rad Laboratories ZenTech S.A. Covidien PLCes AB ACIEX ParkinElmer Inc. Masimo Corporation © Coherent Market Insights. All Rights Reserved © Coherent Market Insights. All Rights Reserved
Global New Born Screening Market Share (%), By Test Type, 2021 55.6% ? ? ? ? Dry Blood Spot Test Cardiac Test Hearing Test Urine Test Others © Coherent Market Insights. All Rights Reserved © Coherent Market Insights. All Rights Reserved